Type 2 Diabetes Trial, Completed NCT00877851 Sponsor: Queen's University, Belfast Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Trial results

AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

According to the results reported on ClinicalTrials.gov, this trial enrolled 84 people in total — 41 in a group that used a computer-based program and 43 in a control group (meaning they did not use the program). By the end of the study, 32 people in the computer-based program group and 38 in the control group had completed it. The trial was measuring several things related to diabetes management, including diabetes knowledge, goal-setting behaviours, diet, physical activity, body measurements, and markers of cardiovascular risk. The reported data shows results for only one of the outcome measures: diabetes knowledge, which was tested using a questionnaire called the ADKnowl. Scores were recorded as the percentage of questions answered correctly. The computer-based program group scored an average of 67% correct, while the control group scored an average of 64% correct. For all other outcomes — including goal setting, dietary intake, physical activity levels, body measurements, and cardiovascular risk markers — no numerical results were reported in the data submitted to ClinicalTrials.gov. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.

These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.

Type 2 Diabetes Trial, Completed

NCT00877851
Completed Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • You have been medically diagnosed with Type 2 diabetes within the last 2 years
  • You have regular access to a computer

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • You are currently pregnant or breastfeeding
  • You have other health conditions where changing your diet or becoming more physically active would not be safe or recommended (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Queen's University, Belfast
Registry
ClinicalTrials.gov
Start date
1 April 2009
Est. completion
1 December 2010

Where this trial was run

🇬🇧 United Kingdom

These are the locations recorded on the registry, and they are a historical record: this trial is not enrolling, so they are not places you can join it.

Primary endpoints

Between Group Differences in Diabetes Knowledge; Between Group Differences in Goal Setting

Other options

Expanded access pathways

This trial is not enrolling. Other access pathways exist in general: in Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients. Whether it applies to any treatment studied here is a question for your doctor — nothing on this page says it does.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov